Inovio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $-65 | $0 | $0 |
Gross Profit | -745 | -754 | -749 | -741 |
EBITDA | -18,937 | 4,518 | -44,747 | -22,777 |
EBIT | -19,682 | 3,764 | -45,496 | -23,519 |
Net Income | -19,682 | 3,764 | -45,496 | -23,519 |
Net Change In Cash | 0 | -65 | 0 | 0 |
Free Cash Flow | -21,591 | -19,497 | -21,641 | -20,842 |
Cash | 26,271 | 44,273 | 36,567 | 24,351 |
Basic Shares | 691,019 | 468,864 | 52,169 | 38,830 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $65 | $217 | $832 | $10,262 |
Gross Profit | 65 | -2,912 | 832 | 10,262 |
EBITDA | -81,957 | -103,946 | -130,391 | -270,902 |
EBIT | -84,945 | -107,076 | -133,894 | -276,398 |
Net Income | -84,945 | -107,254 | -135,117 | -279,818 |
Net Change In Cash | 65 | 217 | 832 | 10,262 |
Cost of Revenue | -24,788 | |||
Free Cash Flow | -88,915 | -104,564 | -124,686 | -217,184 |
Cash | 44,273 | 65,813 | 14,310 | 46,329 |
Basic Shares | 468,864 | 27,160 | 22,173 | 19,885 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.31 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.87 |
2025-06-30 | -$0.61 |